Login / Signup
Sevda Kanat
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 3
Top Topics
Locally Advanced
Squamous Cell
Radiation Therapy
Top Venues
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Meltem Dağdelen
,
Tuba Kurt Çatal
,
Songül Çavdar Karaçam
,
Emine Sedef Akovalı
,
Sevda Kanat
,
Halil Cumhur Yıldırım
,
Ömer Erol Uzel
Is a total dose of 54 Gy with radiochemotherapy sufficient for treatment of intermediate-risk volumes in nasopharyngeal cancer?
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
200 (5) (2023)
Meltem Dağdelen
,
Tuba Kurt Çatal
,
Songül Çavdar Karaçam
,
Emine Sedef Akovalı
,
Sevda Kanat
,
Halil Cumhur Yıldırım
,
Ömer Erol Uzel
Is a total dose of 54 Gy with radiochemotherapy sufficient for treatment of intermediate-risk volumes in nasopharyngeal cancer?
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
(2023)
Meltem Dağdelen
,
Tuba Kurt Çatal
,
Songül Çavdar Karaçam
,
Emine Sedef Akovalı
,
Sevda Kanat
,
Halil Cumhur Yıldırım
,
Ömer Erol Uzel
Is a total dose of 54 Gy with radiochemotherapy sufficient for treatment of intermediate-risk volumes in nasopharyngeal cancer?
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
200 (5) (2023)